"Peptide stacks" are combinations of two or more peptides used together, marketed for fat loss, healing, anti-aging, and more. They are popular in biohacking circles, but the honest scientific picture is that almost none of these stacks has human trial evidence, most of the individual peptides are not FDA-approved, and several were flagged by the FDA as safety risks. This guide explains the common stacks, what is actually known, and where the real evidence sits.
Do peptide stacks work?
For most marketed peptide stacks, there is no human clinical trial showing the combination works. The popular pairings (CJC-1295 with ipamorelin, BPC-157 with TB-500, NAD+ with epithalon, tesamorelin with sermorelin) are built on animal data, small uncontrolled studies, mechanism-based reasoning, and user reports, not on controlled trials of the stack itself. Where a real human trial exists, it is almost always for a single agent, not the combination. So the honest answer is that peptide stacks are largely experimental.
The clear exception is the GLP-1 weight-loss drugs that sometimes get grouped into "fat loss stacks." Semaglutide has strong Phase 3 evidence (the STEP-1 trial showed about 14.9% average weight loss over 68 weeks), but that is the drug on its own, not a peptide stack.
What is the best peptide stack for fat loss?
There is no fat-loss peptide stack with proven human evidence. The commonly promoted "semaglutide + AOD-9604" combination is a good example of the gap: semaglutide works well on its own, but AOD-9604 (a growth hormone fragment) failed to beat placebo for weight loss in its own clinical testing, and there is no trial showing it adds anything to semaglutide. Adding an unproven peptide to a proven drug adds cost and risk, not confirmed benefit. For fat loss, the evidence points to the GLP-1 medication alone plus diet and activity, not a stack.
What is the best peptide stack for muscle growth or healing?
The growth hormone secretagogue pairing (CJC-1295 with ipamorelin) is the most popular "anti-aging and recovery" stack. It does raise growth hormone and IGF-1 in short studies, but there is no good human trial showing it builds meaningful muscle or reverses aging, and it is not FDA-approved. The healing pairing (BPC-157 with TB-500) is supported mainly by rat studies; controlled human healing trials do not exist. These stacks may sound compelling, but the human evidence is thin to absent.
From the FormBlends catalog
Lean Metabolic
Mitochondrial energy plus targeted fat metabolism. · Bundle from $381 · provider-reviewed peptide bundle.
View Lean Metabolic →Are peptide stacks legal and safe?
Most of these peptides are not FDA-approved for any use. In 2023 the FDA placed BPC-157, TB-500, CJC-1295, ipamorelin, AOD-9604, epithalon, thymosin alpha-1, and others into Category 2, the list of bulk substances presenting significant safety risks for compounding. The FDA cited immunogenicity, manufacturing impurities, and a lack of human safety data. In April 2026 these were removed from Category 2, but that did not make them approved drugs; they have no USP monograph and remain in a regulatory gray zone, with a Pharmacy Compounding Advisory Committee review scheduled for July 2026. Most product sold online is "research use only," not pharmaceutical grade, and its purity is unverified. Safety of these stacks over time is unknown.
Comparison: common peptide stacks and their evidence
| Stack | Marketed for | Human stack evidence | Regulatory status |
|---|---|---|---|
| CJC-1295 + ipamorelin | Anti-aging, recovery | None for the stack | Not approved; was Category 2 |
| Semaglutide + AOD-9604 | Fat loss | None; AOD-9604 failed solo | Semaglutide approved; AOD-9604 not |
| BPC-157 + TB-500 | Healing | Animal data only | Not approved; was Category 2 |
| NAD+ + epithalon | Longevity | None in humans | Not approved |
| Tesamorelin + sermorelin | Visceral fat | Tesamorelin approved for HIV only | Mixed |
Is there an evidence-based "stack" that actually works?
The closest thing to a proven approach is not a peptide stack at all. For weight and metabolic health, an FDA-approved GLP-1 medication (semaglutide or tirzepatide) plus a protein-forward diet, resistance training, and sleep has real outcome data behind it. Tesamorelin is genuinely FDA-approved, but only for excess abdominal fat in people with HIV-associated lipodystrophy, not for general body recomposition. Outside of these, "stacks" are marketing language layered on top of unproven combinations.
How does FormBlends fit in?
FormBlends is a telehealth program for physician-supervised compounded semaglutide and tirzepatide for weight management, and it follows the science on these compounds closely as the regulatory and clinical picture develops. If your interest in a "fat loss stack" really comes down to losing weight, a supervised GLP-1 program is the option with actual clinical evidence behind it. Any decision should be made with a licensed clinician.
Frequently asked questions
Do peptide stacks work?
For most marketed stacks there is no human trial evidence. They rely on animal data and user reports. The exception is GLP-1 weight-loss drugs used alone, which have real trial data.
What is the best peptide stack for fat loss?
None is proven. The popular semaglutide + AOD-9604 combination has no supporting trial, and AOD-9604 failed to beat placebo for weight loss on its own.
What is the best peptide stack for muscle growth and fat loss?
There is no stack with proven human muscle or fat-loss results. CJC-1295/ipamorelin raises growth hormone in short studies but lacks outcome evidence.
Are peptide stacks safe?
Safety is unknown. Most of these peptides are not FDA-approved, were flagged as safety risks in 2023, and are usually sold as unregulated research chemicals.
Is there an anti-aging or longevity peptide stack that works?
No human trial supports the NAD+/epithalon or similar longevity stacks. Claims of telomere lengthening in humans are not established.
What about an anti-inflammatory peptide stack?
Anti-inflammatory peptide combinations like thymosin alpha-1 with LL-37 are not FDA-approved and lack controlled human evidence for this use.
What actually has evidence for fat loss and metabolic health?
FDA-approved GLP-1 medications (semaglutide, tirzepatide) plus diet, resistance training, and sleep have real clinical outcome data, unlike marketed peptide stacks.
Related guides
- The Fat Loss Trifecta: Peptide Stacks for Body Recomposition
- 5-amino-1mq for Skin Healing and Anti-aging
- Aod-9604 for Skin Healing and Anti-aging
- Bpc-157 for Skin Healing and Anti-aging
- Cjc-1295 for Skin Healing and Anti-aging
- Epithalon for Skin Healing and Anti-aging
Sources
- STEP-1 semaglutide weight loss trial, New England Journal of Medicine, 2021: https://www.nejm.org/doi/full/10.1056/NEJMoa2032183
- FDA, Interim Policy on Compounding Using Bulk Drug Substances (503A): https://www.fda.gov/media/174456/download
- FDA, bulk drug substances categories and the 503A review: https://www.fda.gov/drugs/human-drug-compounding/bulk-drug-substances-nominated-use-compounding
- Falutz J et al., tesamorelin for visceral fat in HIV lipodystrophy, NEJM: https://www.nejm.org/doi/full/10.1056/NEJMoa073184
- AOD-9604 weight-loss clinical results overview (failed primary endpoint): https://pubmed.ncbi.nlm.nih.gov/?term=AOD-9604+obesity+clinical+trial
- NIH MedlinePlus, growth hormone and aging: https://medlineplus.gov/ency/article/004015.htm
See your options in about 2 minutes
Take the free quiz and see what fits you. Quick, private, and no commitment to continue.
See my options →